prostatepedia magazine covers

 

Prostatepedia features informal conversations with doctors, patients, and activists about prostate cancer. Each month they tackle a different topic facing prostate cancer patients today—from how imaging has impacted treatment to dealing with erectile dysfunction after radiation or surgery to the evolving field of immunotherapy.

Prostatepedia Magazine (quarterly) and the weekly Prostatepedia Digests became part of NASPCC starting with the August 2020 issue.

Use this link to learn more about Prostatepedia...

naspcc logo“Educate, Participate and Celebrate”

November 4-6, 2022
Fairmont Hotel, Washington, DC

Please use this link to download and print out a PDF version of this agenda

 

 

Agenda

Friday, November 4, 2022

Reception 6:30 - 9:00 PM - Fairmont Hotel

 

Saturday, November 5, 2022

SESSION NAME

TIME

 

Breakfast

I. THE BASICS

8:00 – 8:45

 

1.   Introduction and Welcome

9:00-9:10

*Merel Nissenberg, Esq.

2. Prostate Cancer in 2022:

9:10-9:35

*Vincent Laudone, MD

              Memorial Sloan Kettering, New York             

3. Prostate Cancer Genetics

9:35-10:00

*Jacob Berchuck, MD

Predictive Genetic Testing and

 

Dana Farber Cancer Institute

Testing after Diagnosis

 

Harvard Medical School, Boston

4. Pathology: Aggressive Variant

10:20-10:40

*Jonathan Epstein, MD

Prostate Cancer &/or

Treatment-Associated Small Cell

Neuroendocrine Prostate Cancer

 

Johns Hopkins, Baltimore

5. Androgen Deprivation Therapy

10:40-11:10

*Mark Markowski, MD

and Novel Anti-Androgens

 

Johns Hopkins, Baltimore

MORNING BREAK

II. LOCALIZED PROSTATE CANCER

11:10-11:15

 

6. Active Surveillance, Surgery

11:15-11:45

*Vincent Laudone, MD

Memorial Sloan Kettering

7. Radiation, Focal Therapy

11:45-12:15

         *Daniel Spratt, MD,                 

Case Comprehensive Cancer Center

*Daniel Song, MD

Johns Hopkins, Baltimore

   Q&A

12:00-12:15

All

LUNCH  

III. PSA RECURRENT DISEASE

12:15-1:00

   

8. PSMA PET and Functional Imaging

1:15-1:35

*Thomas Hope, MD UCSF, San Francisco

 

9. PSA Persistence

1:35-1:55

*Daniel Spratt, M.D

 

and Recurrence: Salvage Therapy

 

Case Comprehensive Cancer Center

 

10. Oligometastatic Disease:

1:55-2:15

*Daniel Song, MD

 

Metastasis-Directed Therapy and SBRT

 

Johns Hopkins, Baltimore

 

   Q&A

IV. ADVANCED PROSTATE CANCER

2:15-2:30

All

 

11. Treatment Options and

2:30-3:10

*Mark Markowski, MD

 

Treatment Sequencing:

 

*Andrew Armstrong, MD

 

BAT and Other New Combinations

 

Duke Medical Center, Durham, NC

 

   Q&A

3:10-3:30

All

 

V. PRECISION MEDICINE IN PROSTATE CANCER

 

12. PSMA Expression on Circulating                                  3:30-3:50

*Andrew Armstrong, MD

 

Tumor Cells and the PROpel data;

PROPHECY Trial; HRR Mutations

Duke Medical Center, Durham, NC

 

   Q&A                                                                                     3:50-4:00

VI. IMMUNO-ONCOLOGY IN PROSTATE CANCER

All

 

13. Car-T Cell Therapy and Bi-Specifics                             4:00-4:20

*Vivek Narayan, MD, MS University of Pennsylvania

 

14. Vaccine Strategies and                                                  4:20-4:40

*James L. Gulley, MD, PhD

 

Checkpoint Inhibitors

National Institutes of Health                   

 

   Q&A                                                                                     4:40-5:00

All

 
 ADJOURN - Dinner and cocktails start at       6:30 P.M.            

                       

DINNER PRESENTATION: “PSMA-Lutetium and Theranostics”   Thomas Hope, MD

UC San Francisco Department of Radiology and Biomedical Imaging associate professor and director of molecular therapy in the Molecular Imaging & Therapeutics Section, and now Vice Chair, Clinical Operations and Strategy

AWARDS PRESENTATION TO FOLLOW

 

 

Sunday, November 6, 2022

Breakfast                                                                                8:00-8:45

IV. OTHER CONSIDERATIONS and FUTURE DIRECTIONS

 
 SESSION NAME  TIME

15. General Primer on Genomics

8:45-9:00

*Chris Bland,

Pfizer, US Medical Affairs

16. Somatic Testing in Prostate Cancer

9:00-9:20

*Jacob Berchuck, MD

   Q&A

9:20-9:30

All

17. New Directions in Radiotherapy

9:30-9:55

*Michael Zelefsky, MD

Revolutionizing the Treatment of Prostate Cancer

 

Memorial Sloan Kettering, NY

18. A Validated Prostate Cancer Map

9:55-10:10

*Alan Priester, PhD

to Aid In Focal Treatment Planning

 

Avenda Health

   Q&A

10:10-10:25

All

19. PROMISE Registry

10:25-10:40

*Kathy Wiedemer

Steering Committee,

PROMISE Registry

BREAK

11:10-11:15

 

20. “My Prostate Cancer Journey”

10:50-11:10

*Paul Williams             

   Discussion

11:10-11:20

*Clarence Williamson,

*David Sauls

ELECTIONS for 2023 Board

11:20-11:45

Jan Marfyak,   Secretary

21. Panel on Survivorship:

11:45-12:15

*Michael Zaragoza, MD

ED and Emotional Distress Issues

 

*Paul Williams, *Tony Minter,

*David Sauls

LUNCH

12:15-1:00

 

22. Report from the

1:00-1:10

*Thomas Kirk, Chair

STEERING COMMITTEE

   

23. A NEW 5-YEAR STRATEGIC PLAN

1:10-1:45

*LaTanya Patton, Merel Nissenberg

24. Attendees’ General Discussion

1:45-2:00

*All Attendees  

25. Calendaring and Wrap-Up

2:00-2:15

*Merel Nissenberg

17TH ANNUAL MEETING ADJOURNS                                 2:15 p.m.

Attachments:
Download this file (naspcc_program_agenda.pdf)17th Annual Meeting - Agenda - PDF[ ]204 kB